Keyword search (4,028 papers available)


The Impact of Coronary Artery Disease on Brain Vascular and Metabolic Health: Links to Cognitive Function

Author(s): Sanami S; Tremblay SA; Rezaei A; Potvin-Jutras Z; Sabra D; Intzandt B; Gagnon C; Mainville-Berthiaume A; Wright L; Gayda M; Iglesies-Grau J;...

Coronary artery disease (CAD), the leading cause of mortality worldwide, is increasingly recognized for its impact on brain health and cognition, yet the mechanisms linking CAD to vascular and meta...

Article GUID: 41452711

Basic Science and Pathogenesis

Author(s): Hervé V; KaAli OB; Benali H; Brouillette J;

Background: One of the main neuropathological hallmarks of Alzheimer's disease (AD) is the accumulation of amyloid-beta oligomers (Aßo), which begins in the brain approximately 15 years prior to the onset of clinical symptoms. Aßo-induced neuronal hyper...

Article GUID: 41436083

Alzheimer s Imaging Consortium

Author(s): Mitchell SW; Chan T; Trudel L; Hosseini SA; Macedo AC; Gonçalves MP; Rahmouni N; Hall BJ; Socualaya KMQ; Therriault J; Servaes S; Bezgin G; ...

Background: Brain and cognitive resilience (BR, CR) reflect the capacity to maintain structural integrity and cognitive function despite pathological tau deposition in Alzheimer's disease (AD)....

Article GUID: 41433447

Public Health

Author(s): Gurve D; Centen AP; Slack PJ; Dang-Vu TT; Belleville S; Anderson ND; Montero-Odasso M; Nygaard HB; Chertkow H; Feldman HH; Brewster PWH; Lim...

Background: Older adults experience considerable day-to-day variability in cognitive function. We aimed to test the hypothesis that this is in part related to sleep, and determine which EEG sleep f...

Article GUID: 41434309

Basic Science and Pathogenesis

Author(s): Lamontagne-Kam D; Rahimabadi A; Bello DG; Lavallée-Beaulieu M; Fermawi AE; Bonenfant L; Nanci A; Benali H; Brouillette J;...

Background: Tau pathology is an important neuropathological marker of Alzheimer's Disease (AD) and correlates closely with neurodegeneration and cognitive decline. To date, much of the work exa...

Article GUID: 41435278

Pontine Functional Connectivity Gradients

Author(s): Rousseau PN; Bazin PL; Steele CJ;

Article GUID: 41420671

Patterns of Structural Disconnection Driving Proprioceptive Deficits in Chronic Stroke

Author(s): Kaeja M; Gajiyeva L; Iturria-Medina Y; Villringer A; Sehm B; Steele C;

Background: Stroke is a leading cause of death and disability, with proprioceptive impairments affecting up to 64% of survivors. These impairments hinder sensorimotor recovery, significantly impacting poststroke quality of life. Proprioception depends on an...

Article GUID: 41392885

Canadian Spine Society: 25th Annual Scientific Conference, February 25 to 28, 2025, Fairmont Le Manoir Richelieu, La Malbaie, Charlevoix, Que., Canada

Author(s): Chan V; Gausper A; Liu A; Andras LM; Illingworth KD; Skaggs DL; Imbeault R; Dufresne J; Parent S; Deschênes S; Roy-Beaudry M; Legler J; Benaroch L; Pirshahid AA; Serhan O; Cheng D; Bartley D; Carey...

Article GUID: 41386990

Longitudinal effects of cerebrovascular reactivity and cerebral pulsatility in cognitively intact older adults with APOE4: links with cognition

Author(s): Potvin-Jutras Z; Tremblay PL; Mohammadi H; Villeneuve S; Spreng RN; Gauthier CJ;

The apolipoprotein E4 (APOE4) allele is the strongest genetic risk factor for Alzheimer's disease (AD) and is linked to poorer cerebrovascular health. Cerebrovascular reactivity (CVR), an indicator of vascular reserve, and cerebral pulsatility (CP), a m...

Article GUID: 41353310


Title:Public Health
Authors:Gurve DCenten APSlack PJDang-Vu TTBelleville SAnderson NDMontero-Odasso MNygaard HBChertkow HFeldman HHBrewster PWHLim A
Link:https://pubmed.ncbi.nlm.nih.gov/41434309/
DOI:10.1002/alz70860_107491
Category:
PMID:41434309
Dept Affiliation: PERFORM
1 University of Toronto, Toronto, ON, Canada.
2 Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
3 University of British Columbia, Vancouver, BC, Canada.
4 Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, QC, Canada.
5 PERFORM Centre, Concordia University, Montreal, QC, Canada.
6 Concordia University, Montreal, QC, Canada.
7 Research Centre, Institut universitaire de gériatrie de Montréal, Montreal, QC, Canada.
8 Department of Psychology, Université de Montréal, Montreal, QC, Canada.
9 Rotman Research Institute, Baycrest Academy for Research and Education, Toronto, ON, Canada.
10 Rotman Research Institute, Toronto, ON, Canada.
11 Ben & Hilda Katz Interprofessional Research Centre in Geriatric and Dementia Care, Toronto, ON, Canada.
12 Kimel Family Centre for Brain Health and Wellness, Toronto, ON, Canada.
13 Western Univeristy, London, ON, Canada.
14 Lawson Health Research Institute, London, ON, Canada.
15 Schulich School of Medicine & Dentistry, Division of Geriatric Medicine, Western University, London, ON, Canada.
16 UBC Hospital Clinic for Alzheimer Disease and Related Disorders, Vancouver, BC, Canada.
17 Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
18 Kimel Family Centre for Brain Health and Wellness and Anne & Allan Bank Centre for Clinical Research Trials, Baycrest Health Sciences, Toronto, ON, Canada.
19 Baycrest and Rotman Research Institute, Toronto, ON, Canada.
20 Baycrest Academy, Toronto, ON, Canada.
21 University of California San Diego, Department of Neurosciences, La Jolla, CA, USA.
22 Alzheimer's Disease Cooperative Study (ADCS), University of California San Diego, La Jolla, CA, USA.
23 Cognition & Technology Research Group, Institute on Aging and Lifelong Health, University of Victoria, Victoria, BC, Canada.
24 University of Victoria, Victoria, BC, Canada.

Description:

Background: Older adults experience considerable day-to-day variability in cognitive function. We aimed to test the hypothesis that this is in part related to sleep, and determine which EEG sleep features are most important in supporting day to day cognitive resilience.

Method: We analyzed data from 149 adults at high risk for dementia participating in the Brain Health Pro (BHPro) study. At BHPro baseline, participants underwent up to 3 nights of overnight ambulatory EEG using the MUSE-S (Interaxon, Toronto, Canada) as well as multi-day app-based cognitive testing (MyCogHealth, Victoria, Canada). Of 350 participants, 149 had EEG and cognitive evaluation that overlapped by at least 1 day. We performed automated sleep staging and computed frontal NREM (N2 and N3) delta power and REM theta power. We used linear mixed effect models to relate each morning's composite global cognitive test results to the previous night's sleep measures.

Result: 149 individuals had >=1 cognitive evaluation within 12 hours of an overnight EEG recording. Of these, 63 had 2 nights, and 37 had >=3 nights. Greater % REM sleep (+0.15 per 1SD greater REM sleep, SE 0.04 p = 0.0001) and relative REM theta power (+0.08 per 1SD greater relative REM theta power, SE 0.04, p = 0.02) the night before were associated with better cognitive performance the next morning, and there was a non-significant positive relationship (+0.06 per 1SD difference, SE 0.04, p = 0.11) between NREM delta power and cognitive performance the following morning. These effects were particularly strong in those with mild cognitive impairment (delta power interaction p = 0.055; theta power interaction p = 0.02) CONCLUSION: REM sleep theta power and NREM delta power may support day to day cognitive performance in older adults at high risk for dementia, particularly those with mild cognitive impairment, and may represent electrophysiologic therapeutic targets to support cognitive resilience.